Baker Brothers Advisors - TALIS BIOMEDICAL CORP ownership

TALIS BIOMEDICAL CORP's ticker is TLIS and the CUSIP is 87424L108. A total of 30 filers reported holding TALIS BIOMEDICAL CORP in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Baker Brothers Advisors ownership history of TALIS BIOMEDICAL CORP
ValueSharesWeighting
Q1 2023$3,736,169
+9.9%
7,624,8350.0%0.02%0.0%
Q4 2022$3,398,389
-34.6%
7,624,8350.0%0.02%
-41.2%
Q3 2022$5,197,000
-16.1%
7,624,8350.0%0.03%
-2.9%
Q2 2022$6,191,000
-42.4%
7,624,8350.0%0.04%
-43.5%
Q1 2022$10,751,000
-64.8%
7,624,8350.0%0.06%
-58.4%
Q4 2021$30,576,000
-35.4%
7,624,835
+0.7%
0.15%
-28.4%
Q3 2021$47,343,000
-43.3%
7,574,8350.0%0.21%
-43.3%
Q2 2021$83,550,000
-14.2%
7,574,8350.0%0.37%
-13.0%
Q1 2021$97,337,0007,574,8350.42%
Other shareholders

There were no reported owners of TALIS BIOMEDICAL CORP in Q3 2022.

NameSharesValueWeighting ↓
View complete list of TALIS BIOMEDICAL CORP shareholders